Business ❯ Biotechnology

Clinical Research

Drug Development Pharmaceuticals Pharmaceutical Companies Regulatory Affairs Product Development Celcuity Inc. Nanotechnology Investor Relations PulseSight Therapeutics Drug Approval Process FDA Designation Drug Trials Cancer Treatment Regulatory Approval Cancer Therapies Drug Efficacy Therapeutics Drug Applications Oncology Cell Therapy Immunotherapy Acquisitions

Theriva’s VCN-01 Extends Survival in Phase 2b Pancreatic Cancer Trial, Paving Way to Phase 3

Responses that grew over time suggest an immune effect worth testing with extended dosing.

Atrogi Begins Dosing in 8-Week Human Study of GRK2-Biased β2 Agonist ATR-258

Gilead to Acquire Arcellx for Up to $7.8 Billion to Gain Full Control of CAR-T Anito-Cel

Wave Life Sciences Soars on Obesity Trial Signal as It Begins $250 Million Stock Offering

Exicure’s Burixafor Delivers About 90% Stem-Cell Mobilization in Phase 2 as Shares Surge

Protara Reports Strong Interim Phase 2 Results for TARA-002 in Pediatric Lymphatic Malformations

Rapport Seizure Drug Posts Strong Phase 2 Signal as Company Plans Phase 3